SOLV — Solventum Corporation

Solventum Corporation (SOLV) 是一家 Medical - Care Facilities 公司，屬於醫療保健產業, 目前交易價格為 $69.02. 其SharesGrow評分為 73/100, 表明高於平均的投資特徵， 7項中通過6項.

SharesGrow calculates the intrinsic value of SOLV = $6.98 (-89.9% 相對於當前價格, 該股票看起來被高估). 分析師共識目標價為 SOLV = $101 (+45.6% 上漲空間).

估值: SOLV 本益比(P/E)為 7.2 (S&P 500平均約25) 前瞻PEG為 0.85.

財務數據: 營收為 $8.3B, +0.8%/yr 平均成長. 淨利潤為 $1.6B, 成長率為 +53.6%/yr. 淨利潤率為 18.7% (健康). 毛利率為 53.5% (-4.2 pp 趨勢).

資產負債表: 總債務為 $5.0B 對比 $5.0B 股東權益 (D/E比率 1, 適度). 流動比率為 1.23 (充足). 資產負債率為 35.2%. 總資產: $14.3B.

分析師展望: 7 / 11 位分析師評級 SOLV 為買入 (64%) — 適度共識.

SharesGrow 7項標準細分: Value 76/100 (Pass), Growth 73/100 (Pass), Past 100/100 (Pass), Health 50/100 (Partial), Moat 71/100 (Pass), Future 73/100 (Pass), Income 70/100 (Pass).

$100.50

▲ 45.61% 上漲空間

Average Price Target

基於 11 位華爾街分析師對 Solventum Corporation 提供的12個月價格目標，平均目標價為 $100.50，最高預測為 $105.00，最低預測為 $97.00。

Highest Price Target

$105.00

Average Price Target

$100.50

Lowest Price Target

$97.00

SOLV SharesGrow 評分概覽

73/100

SharesGrow Score

Above average fundamentals

View full scorecard →

價值 76/100

估值 — P/E, PEG, Forward PEG

成長 73/100

財務數據 — 平均成長

過去 100/100

強勁 — 趨勢

健康 50/100

資產負債表 — D/E比率, 流動比率為

護城河 71/100

毛利率為 + market cap

未來 73/100

分析師展望 — 為買入

收入 70/100

淨利潤率為

Scores derived from financial statements, analyst ratings, and balance sheet data.

評分明細 — SOLV

✓

價值 Pass

76/100

SOLV 本益比(P/E)為 7.2 (S&P 500平均約25). Forward PEG 0.85 — Peter Lynch 被低估 (≤1.0). Trailing PEG 3.49. 分析師共識目標價為 $101, 意味著 +46.3% 相對於當前價格 $69. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上漲空間 (25%) + trailing PEG (20%). ≥ 60 = Pass.

SOLV: +0.8%/yr 營收為, +53.6%/yr 淨利潤為平均成長. 一般. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

SOLV: 4 / 4 年獲利. 強勁 — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

資產負債表 SOLV: D/E比率 1 (適度), 流動比率為 1.23 (充足). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

SOLV: 毛利率為 53.5% (-4.2 pp 趨勢), $12B market cap. Moat (0-100): margin (35%) + 趨勢 (15%) + market cap (30%) + 營收為 (20%). Score 71/100. ≥ 70 = Pass.

分析師展望: 7 / 11 位分析師評級 SOLV 為買入 (64%). 分析師共識目標價為 $101 (+46.3% 上漲空間). Score: 60% buy consensus + 40% 上漲空間. ≥ 60 = Pass.

SOLV: 淨利潤率為 18.7%. 健康 (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

市場數據

52週區間60.7-88.2

成交量1.14M

30日平均成交量1.4M

市值$11.97B

Beta（1年）0.77

Share Statistics

EPS（TTM）8.94

流通股數$174.1M

IPO Date2024-04-01

Employees22,000

CEOBryan C. Hanson

Financial Highlights & Ratios

Revenue (TTM)$8.33B

Gross Profit$4.45B

EBITDA$2.55B

Net Income$1.56B

Operating Income$2.18B

Total Cash$878M

Total Debt$5.04B

Net Debt$4.16B

Total Assets$14.29B

Price / Earnings (P/E)7.7

Price / Sales (P/S)1.44

Analyst Forecast

1Y Price Target$100.00

Target High$105.00

Target Low$97.00

上漲空間+44.9%

評級共識Buy

覆蓋分析師數11

買入 64% 持有 27% 賣出 9%

Price Target Summary

公司資訊

國家US

交易所NYSE

貨幣USD

ISINUS83444M1018

股價走勢

SOLV

Solventum Corporation ↗ · NYSE

Healthcare • Medical - Care Facilities

60.70 52WK RANGE 88.20

其他人也在看

ALGN

Align Technology, Inc.

$184.69

+2.23%

ELAN

Elanco Animal Health Incorporated

$24.11

+1.05%

UHS

Universal Health Services, Inc.

$181.95

-0.68%

ENSG

The Ensign Group, Inc.

$198.45

-0.92%

RDY

Dr. Reddy's Laboratories Limited

$13.13

-1.06%

EHC

Encompass Health Corporation

ICON Public Limited Company

$113.06

+2.44%

Solventum Corporation SOLV NYSE

SOLV SharesGrow 評分概覽

評分明細 — SOLV

Stock Chart & Stats

股價走勢

其他人也在看

獲取低估股票提醒